Pristine Surgical completes $18 million capital raise

MANCHESTER, N.H., March 17, 2020 /PRNewswire/ — Pristine Surgical LLC, makers of the first fully-integrated, single-use visualization platform for rigid endoscopic surgical and diagnostic procedures, announced today that it completed its third round of investment capital raising.  The capital round, totaling $18 million, funds the completion of the company’s high-volume manufacturing capability, product launch and roadmap expansion. 

“We are grateful for the support of our new and existing investors who are eagerly anticipating the launch of our single-use platform,” said Bryan Lord, Pristine’s chief executive officer.  “We will give hospitals and surgery centers the full confidence that their arthroscopic and laparoscopic procedures are performed with high-performance digital scopes, delivered in 100% sterile single-use kits, and at a reduced cost.”

Pristine Surgical has developed a first-of-its-kind, single-use visualization platform for surgical and diagnostic rigid endoscopic procedures by combining state-of-the-art, high-definition digital imaging with advanced LED lighting, artificial intelligence and cloud-based software.  Its single-use arthroscopes and laparoscopes are delivered in a 100% sterile kit, and together with its cloud-based workflow reduction software, promises to reduce cost, reduce risk and increase efficiency for over 23 million procedures per year.

Headquartered in Manchester, New Hampshire in the greater Boston medical device cluster, Pristine is led by an experienced management team, a seven-person board of directors and a ten-person medical advisory board. 

For more, see www.pristinesurgical.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/pristine-surgical-completes-18-million-capital-raise-301025693.html

SOURCE Pristine Surgical

Staff

Recent Posts

Back Pain, Prostatitis, Enlarged Prostate (BPH) and Kidney Stones are Treated with the Safest Thermobalancing Therapy

The first safe therapy with Dr Allen's Device has once again proved its ability to…

3 hours ago

Defence Completes 2nd Tranche of Financing

Vancouver, British Columbia--(Newsfile Corp. - March 22, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:…

23 hours ago

Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products,…

1 day ago

Axonics Stockholders Approve Merger Agreement with Boston Scientific

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) announced that its stockholders have voted today to adopt…

1 day ago

Pramana Achieves Industry-Leading Milestone with Digital Pathology 2.0 Technology

Over 6.5 Million Glass Slides Digitized in the Last 12 Months and 15 Billion Images…

1 day ago